Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Hiroji Iwata, MD, PhD, Aichi Cancer Center Hospital, Nagoya, Japan, provides an overview of neoadjuvant therapy, highlighting the increased use of endocrine therapy during the COVID-19 pandemic. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.